HTML Microdata document

This HTML5 document contains 76 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n4	http://linked.opendata.cz/resource/mesh/concept/
rdfs	http://www.w3.org/2000/01/rdf-schema#
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
owl	http://www.w3.org/2002/07/owl#
n3	http://linked.opendata.cz/ontology/mesh/
nci	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#
xsdh	http://www.w3.org/2001/XMLSchema#

Statements

Subject Item: nci:C3247
rdf:type: owl:Class
rdfs:label: Myelodysplastic Syndrome
owl:equivalentClass: _:vb635867
nci:A8: nci:C103128 nci:C102905
nci:P106: Neoplastic Process
nci:P108: Myelodysplastic Syndrome
nci:P207: C0033027
nci:P322: CTEP
nci:P325: <n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>A group of diseases in which the bone marrow does not make enough healthy blood cells.</n0:def-definition><n0:def-source>NCI-GLOSS</n0:def-source></n0:ComplexDefinition> <n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>A disorder characterized by insufficiently healthy hematapoietic cell production by the bone marrow.</n0:def-definition><n0:def-source>CTCAE</n0:def-source></n0:ComplexDefinition>
nci:P334: 9989/3
nci:P363: Undetermined
nci:P366: Myelodysplastic_Syndrome
nci:P90: <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Myelodysplastic Neoplasm</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>MDS</n0:term-name><n0:term-group>AB</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Hematopoeitic - Myelodysplastic Syndrome (MDS)</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Smoldering Leukemia</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>preleukemia</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000045480</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>smoldering leukemia</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000046583</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Myelodysplastic Syndrome/Neoplasm</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Oligoblastic Leukemia</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>myelodysplastic syndromes</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000045266</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Myelodysplastic Syndrome</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Dysmyelopoietic Syndrome</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Preleukemia</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Myelodysplastic Syndrome</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source><n0:source-code>TCGA</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Myelodysplastic syndrome, NOS</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>CTEP</n0:term-source><n0:source-code>10028534</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>myelodysplasia</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000045953</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Myelodysplastic syndrome</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>CTCAE</n0:term-source><n0:source-code>E12552</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Myelodysplasia</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
nci:P97: <n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001)</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>
nci:code: C3247
n3:hasConcept: n4:M0017531

Subject Item: _:vb635867
rdf:type: owl:Class
owl:intersectionOf: _:vb729844

Subject Item: _:vb694298
rdf:type: owl:Restriction
owl:onProperty: nci:R108
owl:someValuesFrom: nci:C36235

Subject Item: _:vb694299
rdf:type: owl:Restriction
owl:onProperty: nci:R108
owl:someValuesFrom: nci:C36252

Subject Item: _:vb694300
rdf:type: owl:Restriction
owl:onProperty: nci:R108
owl:someValuesFrom: nci:C36216

Subject Item: _:vb694301
rdf:type: owl:Restriction
owl:onProperty: nci:R108
owl:someValuesFrom: nci:C36223

Subject Item: _:vb694302
rdf:type: owl:Restriction
owl:onProperty: nci:R101
owl:someValuesFrom: nci:C12431

Subject Item: _:vb694303
rdf:type: owl:Restriction
owl:onProperty: nci:R115
owl:someValuesFrom: nci:C35788

Subject Item: _:vb729844
rdf:first: nci:C7588
rdf:rest: _:vb731892

Subject Item: _:vb731892
rdf:first: nci:C35501
rdf:rest: _:vb735842

Subject Item: _:vb735842
rdf:first: nci:C9290
rdf:rest: _:vb739200

Subject Item: _:vb739177
rdf:first: nci:C27274
rdf:rest: _:vb775012

Subject Item: _:vb739200
rdf:first: nci:C54705
rdf:rest: _:vb739177

Subject Item: _:vb775012
rdf:first: _:vb694298
rdf:rest: _:vb775013

Subject Item: _:vb775013
rdf:first: _:vb694299
rdf:rest: _:vb775014

Subject Item: _:vb775014
rdf:first: _:vb694300
rdf:rest: _:vb775015

Subject Item: _:vb775015
rdf:first: _:vb694301
rdf:rest: _:vb775016

Subject Item: _:vb775016
rdf:first: _:vb694302
rdf:rest: _:vb775017

Subject Item: _:vb775017
rdf:first: _:vb694303
rdf:rest: rdf:nil